Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
The Biology and Clinical Uses of Blood Stem Cells
1997 • 729 citations
Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
1995 • 659 citations
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
1996 • 633 citations
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
1995 • 625 citations
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma
1994 • 484 citations
Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.
1992 • 427 citations
Autologous progenitor cell transplantation: prior exposure to stem cell- toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts
1995 • 235 citations
High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation
1998 • 186 citations
Hematopoietic growth factors and human megakaryocyte differentiation.
1992 • 172 citations
Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma.
1997 • 147 citations
Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
1996 • 133 citations
Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
1998 • 124 citations
Factors influencing collection of peripheral blood progenitor cells following high‐dose cyclophosphamide and granulocyte colony‐stimulating factor in patients with multiple myeloma
1997 • 112 citations
Peripheral Blood Stem Cell Mobilization by Chemotherapy With and Without Recombinant Human Granulocyte Colony-Stimulating Factor
1992 • 105 citations
Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors
1992 • 103 citations
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
1995 • 94 citations
Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim
1998 • 90 citations
Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
1997 • 90 citations
Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells
1992 • 83 citations
Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system
1997 • 80 citations
Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections
1996 • 74 citations
Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.
1997 • 69 citations
Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte‐colony‐ stimulating factor: an analysis of 497 patients
1997 • 62 citations
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate‐dose cyclophosphamide
1997 • 61 citations
Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT).
1996 • 53 citations
Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
1992 • 51 citations
Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
1993 • 49 citations
A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer
1992 • 34 citations
Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy
1994 • 16 citations
Cited By (0)
No citing papers found in database